| Ingredient | Declared | Found | Result |
|---|---|---|---|
| Saffron Extract (Affron®) | 88.5 mg | 89.2 mg | PASS |
| KSM-66® Ashwagandha Root | 300 mg | 301.8 mg | PASS |
| Magnesium Glycinate | 200 mg | 198.4 mg | PASS |
| L-Theanine | 100 mg | 100.6 mg | PASS |
| Rhodiola Rosea (3% Rosavins) | 150 mg | 151.2 mg | PASS |
| Phosphatidylserine | 100 mg | 99.1 mg | PASS |
| BioPerine® Black Pepper | 5 mg | 5.1 mg | PASS |
| Vitamin B6 (P-5-P) | 10 mg | 10.0 mg | PASS |
| Zinc Bisglycinate | 15 mg | 14.8 mg | PASS |
| Metal | USP Limit | Found | Result |
|---|---|---|---|
| Lead (Pb) | < 0.5 ppm | < 0.01 ppm | PASS |
| Cadmium (Cd) | < 0.3 ppm | < 0.01 ppm | PASS |
| Arsenic (As) | < 1.5 ppm | < 0.02 ppm | PASS |
| Mercury (Hg) | < 0.1 ppm | < 0.01 ppm | PASS |
| Test | Specification | Found | Result |
|---|---|---|---|
| Total Aerobic Count | < 1,000 CFU/g | < 10 CFU/g | PASS |
| Yeast & Mould | < 100 CFU/g | < 10 CFU/g | PASS |
| E. coli | Absent / 10g | Not Detected | PASS |
| Salmonella spp. | Absent / 25g | Not Detected | PASS |
| Staphylococcus aureus | Absent / 10g | Not Detected | PASS |
CLINICAL ASSESSMENT
After reviewing the formulation, third-party CoA, and the supporting literature (Chandrasekhar et al. 2012; Lopresti et al. 2019), I can confirm this product meets the criteria I apply when evaluating supplements for patient recommendation. The 88.5mg Affron® dose matches the exact quantity used in peer-reviewed neuroinflammation trials. The inclusion of BioPerine® at 5mg is clinically meaningful — without a bioavailability enhancer, saffron's active compounds are poorly absorbed. Most products on the market use 15–30mg and omit the absorption enhancer entirely.
Serving Size: 2 Capsules · Servings Per Container: 30
† Daily Value not established. All doses reflect the exact amounts used in published, peer-reviewed clinical trials.
Third-party tested by Eurofins for 70+ pesticides, 4 heavy metals, and 16 contaminants. Certificate of Analysis available on request.
KSM-66® and Magnesium Glycinate begin normalising cortisol's circadian rhythm. Most women report falling asleep faster and waking without the 3AM cortisol spike.
Clinical trials show KSM-66® lowers serum cortisol by 27.9% at day 60. Affron® saffron extract resolves neuroinflammation. Afternoon bloating and water retention noticeably decrease.
With cortisol chronically lowered, your body stops receiving the signal to store fat around your midsection. Visceral fat reduction becomes visible. This is the phase that requires the full 90-day supply.
of our successful customers choose the 90-Day Supply to complete the full clinical window.

The clinical dose proven in peer-reviewed trials. Reduces neuroinflammation by 73%, modulates serotonin naturally, and targets the brain inflammation that cortisol causes.